- Investing Ideas
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
15
High return on equity, past performance and sound balance sheet.
15 companies
Sanofi Consumer Healthcare India
Market Cap: ₹105.7b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,595.30
7D
-2.6%
1Y
-7.0%
ALTEOGEN
Market Cap: ₩19.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩369,000.00
7D
0.8%
1Y
0%
Sanofi India
Market Cap: ₹79.3b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,444.30
7D
-3.2%
1Y
-45.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹422.1b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,491.40
7D
1.6%
1Y
-11.1%
Abbott India
Market Cap: ₹540.2b
Operates as a pharmaceutical company in India.
500488
₹25,422.50
7D
-1.5%
1Y
-14.5%
Pharma Mar
Market Cap: €1.7b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€96.95
7D
-0.6%
1Y
19.5%
Highnoon Laboratories
Market Cap: PK₨50.5b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨955.52
7D
-7.8%
1Y
5.1%
GlaxoSmithKline Pakistan
Market Cap: PK₨121.8b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨364.73
7D
-7.3%
1Y
-10.9%
China Resources Jiangzhong PharmaceuticalLtd
Market Cap: CN¥17.2b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥27.69
7D
2.7%
1Y
20.6%
Exelixis
Market Cap: US$11.9b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$46.05
7D
3.8%
1Y
23.8%
Consun Pharmaceutical Group
Market Cap: HK$13.2b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.84
7D
-2.9%
1Y
66.4%
Rigel Pharmaceuticals
Market Cap: US$562.9m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$30.72
7D
-3.3%
1Y
61.2%
Chugai Pharmaceutical
Market Cap: JP¥14.7t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,830.00
7D
5.8%
1Y
6.7%
Gubra
Market Cap: DKK 5.4b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 327.60
7D
-6.4%
1Y
-9.8%
Blue Jet Healthcare
Market Cap: ₹71.7b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹403.35
7D
-4.6%
1Y
-44.2%